BeiGene, a Beijing oncology company, began trading on the Shanghai STAR Board as the last step in its $3.5 billion IPO. The company is now listed in the US, Hong Kong, and Shanghai.
Xinhua Silk Road: Over 1,200 program teams register for Hefei-based global tech talent innovation competition
August 11, 2026
manilatimes.net
